Stock Events

Stock Events

Geovax Labs 

$1.1800
134
+$0.01+0.85% Friday 20:00
-$0.01-0.88%Friday 23:47After hours

Statistics

Day High
1.19
Day Low
1.17
52W High
23.1
52W Low
0.963
Volume
1,905
Avg. Volume
-
Mkt Cap
6.15M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12AugExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-7.75
-5.17
-2.58
-0
Expected EPS
-2.155
Actual EPS
N/A

Financials

-631.91%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
7.91MRevenue
-49.98MNet Income

Analyst Ratings

1.00Average Price Target
The highest estimate is 1.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GOVX. It's not an investment recommendation.
NVIDIA
31
NVDA
Amazon
23
AMZN
Palantir Technologies
21
PLTR
Apple
20
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novavax
NVAX
Mkt Cap1.6B
Novavax is a direct competitor in the development of vaccines for infectious diseases, similar to GeoVax's focus area.
Moderna
MRNA
Mkt Cap31.65B
Moderna is involved in mRNA-based vaccines, competing in the same space as GeoVax with its focus on innovative vaccine technologies.
BioNTech
BNTX
Mkt Cap24.67B
BioNTech competes with GeoVax in the development of vaccines for infectious diseases, including COVID-19, leveraging mRNA technology.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson, through its Janssen Pharmaceuticals division, competes in the vaccine market, including efforts against diseases targeted by GeoVax.
Pfizer
PFE
Mkt Cap138.61B
Pfizer, with its global presence and vaccine portfolio, including a COVID-19 vaccine developed with BioNTech, is a competitor in the vaccine space.
Inovio Pharmaceuticals
INO
Mkt Cap100.37M
Inovio Pharmaceuticals focuses on DNA medicines, including vaccines for infectious diseases, positioning it as a competitor to GeoVax.
GSK
GSK
Mkt Cap107.47B
GlaxoSmithKline, with a broad portfolio of vaccines, competes in the same market as GeoVax, targeting various infectious diseases.
Sanofi
SNY
Mkt Cap103.32B
Sanofi, through its vaccine division Sanofi Pasteur, is a major player in the vaccine market, competing with GeoVax in several areas.
Arbutus Biopharma
ABUS
Mkt Cap962.01M
Arbutus Biopharma is involved in the development of therapeutic solutions for infectious diseases, indirectly competing with GeoVax's vaccine development efforts.

About

GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform. Its product pipeline includes several prophylactic vaccines aimed at preventing illnesses such as COVID-19, human immunodeficiency virus (HIV), Zika virus, malaria, and a range of hemorrhagic fevers like Ebola, Sudan, Marburg, and Lassa. Additionally, GeoVax is developing therapeutic vaccines designed to treat existing conditions, specifically HIV, chronic Hepatitis B infections, and solid tumor cancers. To support its research and development efforts, GeoVax Labs, Inc. has forged partnerships with notable organizations. These collaborators include the National Institute of Allergy and Infectious Diseases (part of the National Institutes of Health), the Centers for Disease Control and Prevention, the U.S. Department of Defense, Emory University, the University of Pittsburgh, and the Burnet Institute. Founded in 1988, GeoVax Labs, Inc. is headquartered in Smyrna, Georgia.
Show more...
CEO
Mr. David Alan Dodd
Employees
17
Country
United States
ISIN
US3736787058

Listings

MU
DE
E8L.MU
STU
DE
E8LA.STU
MU
DE
E8LA.MU
BOATS
BOATS
GOVX.BOATS

0 Comments

Share your thoughts

FAQ

What is Geovax Labs stock price today?▼
The current price of GOVX is $1.18 USD — it has increased by +0.85% in the past 24 hours. Watch Geovax Labs stock price performance more closely on the chart.
What is Geovax Labs stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Geovax Labs stocks are traded under the ticker GOVX.
Is Geovax Labs stock price growing?▼
GOVX stock has fallen by -0.84% compared to the previous week, the month change is a +0% rise, over the last year Geovax Labs has showed a -93.02% decrease.
What is Geovax Labs market cap?▼
Today Geovax Labs has the market capitalization of 6.15M
When is the next Geovax Labs earnings date?▼
Geovax Labs is going to release the next earnings report on August 12, 2026.
What were Geovax Labs earnings last quarter?▼
GOVX earnings for the last quarter are -2.62 USD per share, whereas the estimation was -5.18 USD resulting in a +49.37% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Geovax Labs revenue for the last year?▼
Geovax Labs revenue for the last year amounts to 7.91M USD.
What is Geovax Labs net income for the last year?▼
GOVX net income for the last year is -49.98M USD.
How many employees does Geovax Labs have?▼
As of July 11, 2026, the company has 17 employees.
In which sector is Geovax Labs located?▼
Geovax Labs operates in the Health & Wellness sector.
When did Geovax Labs complete a stock split?▼
The last stock split for Geovax Labs was on January 12, 2026 with a ratio of 1:25.
Where is Geovax Labs headquartered?▼
Geovax Labs is headquartered in Smyrna, United States.